Methods and compounds useful in the synthesis of orexin-2 receptor antagonists

US9416109B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9416109-B2
Application numberUS-201314379063-A
CountryUS
Kind codeB2
Filing dateFeb 14, 2013
Priority dateFeb 17, 2012
Publication dateAug 16, 2016
Grant dateAug 16, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides compounds and methods that are useful for the preparation of compounds useful as orexin-2 receptor antagonists.

First claim

Opening claim text (preview).

That which is claimed is: 1. A process for making a compound of Formula IX: wherein: Ar is phenyl, which phenyl may be unsubstituted, or substituted 1-3 times with substituents independently selected from the group consisting of: halo, C 1-6 alkyl, C 1-6 alkoxy, and haloC 1-6 alkyl; R 2 and R 3 are each independently selected from the group consisting of: hydrogen, C 1-6 alkyl, haloC 1-6 alkyl, C 1-6 alkoxy, and hydroxyC 1-6 alkyl; and Ar′ is a pyridine group: wherein: R 4 is selected from the group consisting of: hydrogen, halo, C 1-6 alkyl, C 1-6 alkoxy, and (C 1-6 alkoxy)C 1-6 alkyl; R 5 is selected from the group consisting of: hydrogen, halo, C 1-6 alkyl, and haloC 1-6 alkyl; and R 6 is selected from the group consisting of: hydrogen, halo, C 1-6 alkyl, haloC 1-6 alkyl, C 1-6 alkoxy, (C 1-6 alkoxy)C 1-6 alkyl, and cyano, comprising the step of reacting a compound of Formula VII: wherein Ar, R 2 and R 3 are as given above, with a compound of Formula X: wherein R 4 , R 5 , and R 6 are as given above, said reacting carried out in an organic solvent in the presence of an organic amine and an amide coupling agent, to prepare said compound of Formula IX, wherein said amide coupling agent is an alkyl phosphonic anhydride. 2. The process of claim 1 , wherein Ar is unsubstituted or substituted 1-3 times with a halo independently selected from the group consisting of: chloro, fluoro, bromo, and iodo, and R 2 and R 3 are each independently selected from the group consisting of: hydrogen and C 1-6 alkyl. 3. The process of claim 1 , wherein said organic solvent is selected from the group consisting of ethyl acetate, N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMA), N-methyl-2-pyrrolidone (NMP), acetone, toluene, acetonitrile, and dichloromethane. 4. The process of claim 1 , wherein said amide coupling agent is a propyl phosphonic anhydride or tri-n-propyl phosphonic anhydride. 5. The process of claim 1 , wherein said compound of Formula IX is: 6. The process of claim 1 , wherein said compound of Formula VII, wherein Ar, R 2 and R 3 are as given in claim 1 , is produced by a process comprising: oxidizing a compound of Formula V: wherein Ar, R 2 and R 3 are as given above, with sodium hypochlorite and sodium chlorite, to thereby make said compound of Formula VII. 7. The process of claim 6 , wherein said oxidizing with sodium hypochlorite and sodium chlorite is carried out simultaneously. 8. The process of claim 6 , wherein said oxidizing is catalyzed with an effective amount of 2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPO). 9. The process of claim 1 , wherein said compound of Formula VII: wherein Ar, R 2 and R 3 are as given in claim 1 , is produced by a process comprising the steps of: a) oxidizing a compound of Formula V:  wherein Ar, R 2 and R 3 are as given above, with a first oxidizing agent, to form an aldehyde of Formula VIII:  wherein Ar, R 2 and R 3 are as given above; and then b) oxidizing the aldehyde of Formula VIII with a second oxidizing agent, to thereby make said compound of Formula VII. 10. The process of claim 9 , wherein the first oxidizing agent is sodium hypochlorite. 11. The process of claim 9 , wherein said oxidizing of step a) is catalyzed with an effective amount of 2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPO). 12. The process of claim 9 , wherein the second oxidizing agent is sodium chlorite. 13. The process of claim 6 , wherein said compound of Formula V, wherein Ar, R 2 and R 3 are as given in claim 6 , is produced by a process comprising the steps of: a) stirring a mixture of: i) a compound of Formula IV:  wherein Ar is as given above, and R 1 is a leaving group; ii) a substituted pyrimidine of Formula VI:  wherein R 2 and R 3 are as given above; iii) a base; and iv) an organic solvent, at a temperature of from 65-70° C., for 1 to 12 hours; and then b) reacting the mixture with an aqueous base for a time of from 2 to 20 hours, to thereby make said compound of Formula V. 14. The process of claim 13 , wherein said compound of Formula IV: wherein Ar is as given in claim 13 , and R 1 is a sulfonate ester leaving group, is produced by a process comprising reacting a compound of Formula III: wherein Ar is as given above, with a compound selected from the group consisting of: tosyl chloride, mesyl chloride, nosyl chloride, toluenesulfonyl chloride, toluenesulfonic anhydride and methanesulfonic anhydride, wherein said reacting is carried out in an organic solvent in the presence of a base, to thereby make said compound of Formula IV. 15. The process of claim 14 , wherein the base is an organic amine or potassium carbonate. 16. The process of claim 14 , wherein the organic solvent is selected from the group consisting of: dichloromethane, tetrahydrofuran, 2-methyltetrahydrofuran, toluene, acetonitrile, and ethyl acetate. 17. The process of claim 14 , wherein said compound of Formula III is: 18. The process of claim 14 , wherein said compound of Formula IV has the absolute stereochemistry of Formula IVa: wherein the compound has an enantiomeric excess (ee) of the Formula IVa stereoisomer of at least 80%. 19. The process of claim 14 , wherein said compound of Formula IV is: 20. The process of claim 14 , wherein said compound of Formula III:

Assignees

Inventors

Classifications

  • by reaction of hydroxy compounds with sulfonic acids or derivatives thereof · CPC title

  • C07C29/147Primary

    of carboxylic acids or derivatives thereof · CPC title

  • by reacting an ester group with a hydroxy group · CPC title

  • C07C309/73Primary

    to carbon atoms of non-condensed six-membered aromatic rings · CPC title

  • with a three-membered ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9416109B2 cover?
The present disclosure provides compounds and methods that are useful for the preparation of compounds useful as orexin-2 receptor antagonists.
Who is the assignee on this patent?
Eisai R&D Man Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07C29/147. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).